克服障碍:在瑞士临床实践中实施药剂师领导的药物遗传服务的策略
Florine M Wiss1,2, Deborah Jakober1, Markus L Lampert1,2
1Pharmaceutical Care, Department of Pharmaceutical Sciences, University of Basel, 4056 Basel, Switzerland.
Genes
|July 27, 2024
概括
药物遗传测试可以个性化药物,但瑞士药房面临实施障碍. 本研究确定了将药剂师领导的药物遗传学服务纳入实践的关键挑战和战略.
科学领域:
- 药理学 药理学是指药理学的学科.
- 实施科学 实施科学
- 医疗保健服务研究 医疗保健服务研究
背景情况:
- 药物遗传学分析显示,对优化个人药物治疗有希望.
- 瑞士药剂师有权发起药物遗传学试验,但它们在药房中的使用率仍然很低.
研究的目的:
- 确定在瑞士实施药剂师领导的药物遗传学服务的促进者和障碍.
- 确定有效的实施策略,将这些服务纳入临床实践.
主要方法:
- 与9名药剂师和9名医生进行了半结构化采访.
- 使用了实施研究的综合框架 (CFIR) 和实施变革的专家建议 (ERIC).
- 使用CFIR-ERIC匹配工具来确定额外的战略.
主要成果:
- 确定了7个促进者和12个实施障碍.
- 常见的障碍包括不清晰的程序,缺乏保险覆盖,知识不足,合作不足,患者沟通问题和不充分的电子健康.
- 确定了23个ERIC战略和45个CFIR-ERIC战略.
结论:
- 显著的障碍阻碍了瑞士药剂师领导的药物遗传服务的整合.
- 突出潜在的实施战略对于推动这些服务的采用至关重要.
更多相关视频
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
10.6K
09:30Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
Published on: August 17, 2022
3.0K
相关概念视频
Analysis of Population Pharmacokinetic Data
244
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
244
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Pharmacokinetic Models: Overview
635
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
635
